Vamikibart (RO7200220)

RO7200220 · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vamikibart (RO7200220), covering 2025-10-22 to 2025-10-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema [Phase 2]